Accueil
Pays ⁄
de |
en |
fr
Contacts
Plan du site
Conditions d´utilisation
Mention d´impression
Profil / Principes
Profil / Principes
Stratégie, Vision,
Mission
Philosophie
Innovation et
Qualité
Histoire
Marché
Organisation
Group Structure
Filiales /
Partenaires
commerciaux
Conseil
d’Administration
Direction
Employés
Nous trouver
Investisseurs
Investisseurs
Documents
d'Investisseurs
Rapport Semestriel
Rapport Annuel
Présentations
Corporate Governance
Stock Info
Stock Info
Ticker Symbole
Assemblée générale
Analystes financiers
IR agenda
Contact / Commande
Médias
Médias
Communiqués de
presse
Offres d’emploi/Carrière
Offres d’emploi/Carrière
Offres d'emploi en
Suisse
Offres d'emploi en
Allemagne
Vous êtes ici:
L'entreprise
/
Médias
/
Communiqués de p...
Communiqués de presse
Communiqués de presse 2011
Ces documents n'existent qu'en
allemand
ou en anglais:
16.12.2011 – Ypsomed is establishing a new subsidiary in Austria
The new Group company is based in Vienna and is led by Patrick Heil, who combines this role with that of General Manager for Switzerland.
(PDF 32 KB)
03.11.2011 – Strategic acquisition - Ypsomed strengthens its position in the diabetes sector
Ypsomed today announces the acquisition of ICU Medical, Inc.’ s Orbit™ diabetes infusion set business. With this acquisition, Ypsomed strengthens its position in the diabetes sector.
(PDF 58 KB)
03.11.2011 – Press Release - Semiannual Results
Operating profit impacted by market expansion activities and currency effects
(PDF 325 KB)
25.10.2011 – Ypsomed insulin pen to be launched in Germany by B. Braun
B. Braun is to distribute the reusable insulin pen Omnifill®, developed by the Burgdorf-based diabetes specialist, together with its human insulins
(PDF 66 KB)
12.10.2011 – Ypsomed strengthens company management
The Technology and Operations division are now directly represented on the management board of the Burgdorf-based diabetes specialist
(PDF 30 KB)
28.09.2011 – Move from the Main to the Domestic Standard segment of the SIX Swiss Exchange
Shares of Ypsomed Holding AG now in the Domestic Standard of the SIX Swiss Exchange
(PDF 33 KB)
20.09.2011 – Ypsomed presents new product innovation at EASD in Lisbon
In early 2012, Ypsomed is to launch the second generation OmniPod® insulin patch pump.
(PDF 35 KB)
26.08.2011 – Reporting standards: switch from IFRS to Swiss GAAP ARR
Ypsomed Holding AG to switch financial reporting standards from IFRS to Swiss GAAP ARR
(PDF 35 KB)
17.08.2011 – Change of CEO at Ypsomed
Richard Fritschi is leaving Ypsomed. Dr. h. c. Willy Michel will assume the roles of CEO and chairman of the Ypsomed Group.
(PDF 28 KB)
09.06.2011 – Ypsomed achieves strong growth with mylife™ Diabetescare
In Germany, already one in three new pump users decide to use the mylife™ OmniPod® insulin patch pump
(PDF 47 KB)
26.05.2011 – Ypsomed 2010/11 business year
Ypsomed is on the right track – However, the transformation takes longer
(PDF 62 KB)
26.04.2011 – Ypsomed expands the mylife™ Diabetescare product range
The new mylife™ Roto™ infusion set with 360-degree freedom of movement
(PDF 66 KB)
Archives
Communiqués de presse 2010
Communiqués de presse 2006
Communiqués de presse 2009
Communiqués de presse 2005
Communiqués de presse 2008
Communiqués de presse 2004
Communiqués de presse 2007
Communiqués de presse 2003
Imprimer la page
|
Haut de page
© Copyright Ypsomed 2003- All rights reserved